Last reviewed · How we verify

Iv Methylprednisolone

Göteborg University · FDA-approved active Small molecule Under review

Iv Methylprednisolone is a Corticosteroid Small molecule drug developed by Göteborg University. It is currently FDA-approved for Multiple sclerosis relapse, Acute spinal cord injury, Severe inflammation and autoimmune conditions. Also known as: Solumedrol.

Methylprednisolone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.

Iv Methylprednisolone is a small molecule used to treat various conditions, including Friedreich Ataxia, Cardiomyopathy, Postoperative Pain, Postoperative Nausea and Vomiting, and Inflammatory Response. It is administered intravenously and has been studied in clinical trials as a potential treatment for these conditions.

At a glance

Generic nameIv Methylprednisolone
Also known asSolumedrol
SponsorGöteborg University
Drug classCorticosteroid
TargetGlucocorticoid receptor
ModalitySmall molecule
Therapeutic areaImmunology
PhaseFDA-approved

Mechanism of action

Methylprednisolone acts as a glucocorticoid receptor agonist, translocating to the nucleus to modulate gene expression of inflammatory mediators. It inhibits phospholipase A2, reducing prostaglandin and leukotriene synthesis, and suppresses T-cell activation and antibody production. When administered intravenously at high doses, it provides rapid anti-inflammatory and immunosuppressive effects.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Iv Methylprednisolone

What is Iv Methylprednisolone?

Iv Methylprednisolone is a Corticosteroid drug developed by Göteborg University, indicated for Multiple sclerosis relapse, Acute spinal cord injury, Severe inflammation and autoimmune conditions.

How does Iv Methylprednisolone work?

Methylprednisolone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.

What is Iv Methylprednisolone used for?

Iv Methylprednisolone is indicated for Multiple sclerosis relapse, Acute spinal cord injury, Severe inflammation and autoimmune conditions, Organ transplant rejection prophylaxis.

Who makes Iv Methylprednisolone?

Iv Methylprednisolone is developed and marketed by Göteborg University (see full Göteborg University pipeline at /company/g-teborg-university).

Is Iv Methylprednisolone also known as anything else?

Iv Methylprednisolone is also known as Solumedrol.

What drug class is Iv Methylprednisolone in?

Iv Methylprednisolone belongs to the Corticosteroid class. See all Corticosteroid drugs at /class/corticosteroid.

What development phase is Iv Methylprednisolone in?

Iv Methylprednisolone is FDA-approved (marketed).

What are the side effects of Iv Methylprednisolone?

Common side effects of Iv Methylprednisolone include Hyperglycemia, Insomnia, Mood changes, Hypertension, Infection risk (immunosuppression), Osteoporosis (with chronic use).

What does Iv Methylprednisolone target?

Iv Methylprednisolone targets Glucocorticoid receptor and is a Corticosteroid.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing